Prime Capital Investment Advisors, LLC United Therapeutics Corp Transaction History
Prime Capital Investment Advisors, LLC
- $6.63 Billion
- Q2 2024
A detailed history of Prime Capital Investment Advisors, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Prime Capital Investment Advisors, LLC holds 1,396 shares of UTHR stock, worth $499,768. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,396
Previous 1,012
37.94%
Holding current value
$499,768
Previous $232,000
91.38%
% of portfolio
0.01%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding UTHR
# of Institutions
619Shares Held
45MCall Options Held
368KPut Options Held
410K-
Black Rock Inc. New York, NY5.47MShares$1.96 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.42MShares$1.58 Billion0.03% of portfolio
-
Wellington Management Group LLP Boston, MA3.29MShares$1.18 Billion0.19% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.86MShares$1.02 Billion12.43% of portfolio
-
State Street Corp Boston, MA2.29MShares$821 Million0.03% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $16.3B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...